Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)
NACompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
November 30, 2004
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Conditions
Benign Prostatic Hypertrophy
Interventions
DRUG
Dutasteride
once daily dosing of 0.5mg Dutasteride for 12 months
All Listed Sponsors
lead
North Florida/South Georgia Veterans Health System
OTHER
NCT00382356 - Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) | Biotech Hunter | Biotech Hunter